Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-07
DOI
10.3389/fgene.2021.795010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
- (2021) Sikai Ling et al. Nature Biomedical Engineering
- Artificial intelligence for diagnosis of inherited retinal disease: an exciting opportunity and one step forward
- (2021) Tien-En Tan et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Partial recovery of visual function in a blind patient after optogenetic therapy
- (2021) José-Alain Sahel et al. NATURE MEDICINE
- The Impact of Disease Activity on 5 year Outcomes in patients undergoing treatment for Neovascular Age Related Macular Degeneration
- (2021) Kelvin Yi Chong Teo et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3, Randomized Trial
- (2020) Steven Yeh et al. OPHTHALMOLOGY
- Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases
- (2020) Viral Kansara et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
- (2020) Fan-Li Lin et al. MOLECULAR THERAPY
- Non-adherence or non-persistence to intravitreal injection therapy for neovascular age-related macular degeneration: a mixed-methods systematic review
- (2020) Mali Okada et al. OPHTHALMOLOGY
- Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study
- (2020) Paul Mitchell et al. PLoS One
- Reprogramming to recover youthful epigenetic information and restore vision
- (2020) Yuancheng Lu et al. NATURE
- Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy
- (2020) Santiago Delgado-Tirado et al. Scientific Reports
- Three-year follow-up of Phase 1 and 2a rAAV.sFLT-1 subretinal gene therapy trials for exudative age related macular degeneration
- (2019) E.P. Rakoczy et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- RNAi therapeutic and its innovative biotechnological evolution
- (2019) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors
- (2019) Peige Song et al. Journal of Global Health
- Surgical Technique for Subretinal Gene Therapy in Humans with Inherited Retinal Degeneration
- (2019) Janet L. Davis et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
- (2019) Anne Louise Askou et al. Molecular Therapy-Nucleic Acids
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial
- (2019) Andreas Stahl et al. LANCET
- Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert Opinion
- (2019) SriniVas R. Sadda et al. OPHTHALMOLOGY
- Guidelines on Diabetic Eye Care
- (2018) Tien Y. Wong et al. OPHTHALMOLOGY
- Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
- (2018) Hemal Mehta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- (2018) Taeyoung Koo et al. Nature Communications
- Gene therapy in inherited retinal degenerative diseases, a review
- (2018) Vitor K. L. Takahashi et al. OPHTHALMIC GENETICS
- Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques
- (2018) Galaxy Y. Cho et al. Molecular Diagnosis & Therapy
- Gene therapy for age-related macular degeneration
- (2017) Nicholas A. Moore et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
- (2017) Kyoungmi Kim et al. GENOME RESEARCH
- Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
- (2017) Peter A. Campochiaro et al. HUMAN GENE THERAPY
- Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma
- (2017) Jeffrey O’Callaghan et al. HUMAN MOLECULAR GENETICS
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
- (2017) Stephen Russell et al. LANCET
- Improved Intravitreal AAV-Mediated Inner Retinal Gene Transduction after Surgical Internal Limiting Membrane Peeling in Cynomolgus Monkeys
- (2017) Kazuhisa Takahashi et al. MOLECULAR THERAPY
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- Genome editing abrogates angiogenesis in vivo
- (2017) Xionggao Huang et al. Nature Communications
- Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
- (2017) David W. Hutton et al. JAMA Ophthalmology
- Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
- (2017) Seth R Flaxman et al. Lancet Global Health
- In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells
- (2017) Andreas Holmgaard et al. Molecular Therapy-Nucleic Acids
- Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8
- (2016) Hanen Khabou et al. BIOTECHNOLOGY AND BIOENGINEERING
- Update on ocular gene therapy and advances in treatment of inherited retinal diseases and exudative macular degeneration
- (2016) Robert B. Garoon et al. CURRENT OPINION IN OPHTHALMOLOGY
- Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents
- (2016) M Gemenetzi et al. EYE
- Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy
- (2016) Charumathi Sabanayagam et al. OPHTHALMIC EPIDEMIOLOGY
- Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy
- (2016) James Lin et al. OPHTHALMOLOGY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
- (2016) Ian J. Constable et al. EBioMedicine
- Ranibizumab for the treatment of wet AMD: a summary of real-world studies
- (2015) V Chong EYE
- Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
- (2015) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications
- (2015) Matthew A. Sochor et al. Scientific Reports
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
- (2015) Xiao-Hui Zhang et al. Molecular Therapy-Nucleic Acids
- Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors
- (2015) Anne Louise Askou et al. Molecular Therapy-Methods & Clinical Development
- Optogenetic Approaches to Restoring Vision
- (2015) Zhuo-Hua Pan et al. Annual Review of Vision Science
- Anti-VEGF Treatment Patterns for Neovascular Age-Related Macular Degeneration Among Medicare Beneficiaries
- (2014) Eleonora M. Lad et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates
- (2014) M A Kotterman et al. GENE THERAPY
- Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates
- (2014) Caroline Le Guiner et al. PLoS One
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries
- (2013) L. M. Ruta et al. DIABETIC MEDICINE
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Juan E. Grunwald et al. OPHTHALMOLOGY
- In Vivo-Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
- (2013) D. Dalkara et al. Science Translational Medicine
- Pathophysiology and treatment of diabetic retinopathy
- (2012) Francesco Bandello et al. ACTA DIABETOLOGICA
- A Brief History of Anti-VEGF for the Treatment of Ocular Angiogenesis
- (2012) Leo A. Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA
- (2012) Anne Louise Askou et al. JOURNAL OF GENE MEDICINE
- Diabetic Retinopathy
- (2012) David A. Antonetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents
- (2011) Roberto Calcedo et al. Clinical and Vaccine Immunology
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
- (2011) Helen A. Mintz-Hittner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ab-Externo AAV-Mediated Gene Delivery to the Suprachoroidal Space Using a 250 Micron Flexible Microcatheter
- (2011) Marc C. Peden et al. PLoS One
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
- (2009) M. Saint-Geniez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More